Clinical Trial Update: A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in Hungary [Phase 3]

View source ↗

Summary

Phase 3 extension study assessing safety and tolerability of NPSP558 in adults with hypoparathyroidism completed with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• NPSP558

Snippet

Sponsor: Shire | Conditions: Hypoparathyroidism | Phase 3 | Status: COMPLETED | Results posted: 2015-03-06